Whether signal
transduction pathways were activated or not, subthreshold concentrations
of 5-HT clearly had a priming action at the 5-HT2A
receptors, such that they require 10-fold-lesser amounts of
dopamine to cause receptor internalization and activation. This
priming is not a mere sensitization of the receptor to an agonist;
an interaction of both 5-HT and dopamine with the receptor is
essential, and it has to occur in a defined temporal sequence.
Such concentrations of dopamine as are required to internalize
the 5-HT-primed receptor are within the range of concentrations
of dopamine present at synapses in the brain. For example,
extracellular concentrations of dopamine in conscious rats has
been reported to be 1 M in rat striatum (28). Potential direct
interactions of dopamine on 5-HT2A receptors would be most
likely in areas of the brain where serotonergic and dopaminergic
neurons coexist, e.g., the ventral tegmental area (VTA) (29).
Because 5-HT receptors are most likely presynaptic to serotonergic
neurons, it is likely that prevailing concentrations of 5-HT
are sufficient to sensitize the 5-HT2A receptors before activation
by dopamine, and this could result in an altered and increased
sensitivity to dopamine. Interestingly, 5-HT2A receptors are
present presynaptically on dopaminergic neurons of the VTA,
and the interaction of these receptors with some antipsychotic
drugs regulates the release of dopamine (30). This dopaminemediated
partial activation and internalization could function in
vivo, as a partial desensitization of synaptic 5-HT2A receptors. In
addition, this process could act as a molecular AND gate,
exhibiting activity only in the presence of both 5-HT and
dopamine in a defined temporal sequence.